|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:LACTB2-ITPR2 (FusionGDB2 ID:43825) |
Fusion Gene Summary for LACTB2-ITPR2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: LACTB2-ITPR2 | Fusion gene ID: 43825 | Hgene | Tgene | Gene symbol | LACTB2 | ITPR2 | Gene ID | 51110 | 3709 |
Gene name | lactamase beta 2 | inositol 1,4,5-trisphosphate receptor type 2 | |
Synonyms | CGI-83 | ANHD|CFAP48|INSP3R2|IP3R2 | |
Cytomap | 8q13.3 | 12p11.23 | |
Type of gene | protein-coding | protein-coding | |
Description | endoribonuclease LACTB2beta-lactamase-like protein 2testicular secretory protein Li 23 | inositol 1,4,5-trisphosphate receptor type 2IP3 receptorIP3R 2cilia and flagella associated protein 48type 2 InsP3 receptor | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q53H82 | Q14571 | |
Ensembl transtripts involved in fusion gene | ENST00000276590, ENST00000517601, ENST00000522447, | ENST00000242737, ENST00000545902, ENST00000381340, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 27 X 21 X 12=6804 |
# samples | 3 | 27 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(27/6804*10)=-4.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: LACTB2 [Title/Abstract] AND ITPR2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | LACTB2(71550783)-ITPR2(26636831), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | LACTB2-ITPR2 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. LACTB2-ITPR2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | LACTB2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 26826708 |
Tgene | ITPR2 | GO:0001666 | response to hypoxia | 19120137 |
Fusion gene breakpoints across LACTB2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ITPR2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUAD | TCGA-91-6828-01A | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
Top |
Fusion Gene ORF analysis for LACTB2-ITPR2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000276590 | ENST00000242737 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
5CDS-intron | ENST00000276590 | ENST00000545902 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
5CDS-intron | ENST00000517601 | ENST00000242737 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
5CDS-intron | ENST00000517601 | ENST00000545902 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
5CDS-intron | ENST00000522447 | ENST00000242737 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
5CDS-intron | ENST00000522447 | ENST00000545902 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
Frame-shift | ENST00000276590 | ENST00000381340 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
Frame-shift | ENST00000517601 | ENST00000381340 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
In-frame | ENST00000522447 | ENST00000381340 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000522447 | LACTB2 | chr8 | 71550783 | - | ENST00000381340 | ITPR2 | chr12 | 26636831 | - | 5160 | 877 | 883 | 3171 | 762 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000522447 | ENST00000381340 | LACTB2 | chr8 | 71550783 | - | ITPR2 | chr12 | 26636831 | - | 0.000174654 | 0.9998254 |
Top |
Fusion Genomic Features for LACTB2-ITPR2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for LACTB2-ITPR2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:71550783/chr12:26636831) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
LACTB2 | ITPR2 |
FUNCTION: Endoribonuclease; cleaves preferentially 3' to purine-pyrimidine dinucleotide motifs in single-stranded RNA. The cleavage product contains a free 3' -OH group. Has no activity with double-stranded RNA or DNA. Required for normal mitochondrial function and cell viability. {ECO:0000269|PubMed:26826708}. | FUNCTION: Receptor for inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium. This release is regulated by cAMP both dependently and independently of PKA (By similarity). {ECO:0000250|UniProtKB:Q9Z329}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 112_166 | 0 | 182.0 | Domain | MIR 1 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 173_223 | 0 | 182.0 | Domain | MIR 2 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 231_287 | 0 | 182.0 | Domain | MIR 3 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 294_372 | 0 | 182.0 | Domain | MIR 4 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 378_434 | 0 | 182.0 | Domain | MIR 5 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 265_269 | 0 | 182.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 507_510 | 0 | 182.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 567_569 | 0 | 182.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 1_2227 | 0 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2249_2260 | 0 | 182.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2282_2307 | 0 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2329_2351 | 0 | 182.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2373_2394 | 0 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2416_2521 | 0 | 182.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2543_2701 | 0 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2249_2260 | 1937 | 2702.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2282_2307 | 1937 | 2702.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2329_2351 | 1937 | 2702.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2373_2394 | 1937 | 2702.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2416_2521 | 1937 | 2702.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2543_2701 | 1937 | 2702.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2228_2248 | 0 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2261_2281 | 0 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2308_2328 | 0 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2352_2372 | 0 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2395_2415 | 0 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000242737 | 0 | 6 | 2522_2542 | 0 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2228_2248 | 1937 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2261_2281 | 1937 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2308_2328 | 1937 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2352_2372 | 1937 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2395_2415 | 1937 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 2522_2542 | 1937 | 2702.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 112_166 | 1937 | 2702.0 | Domain | MIR 1 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 173_223 | 1937 | 2702.0 | Domain | MIR 2 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 231_287 | 1937 | 2702.0 | Domain | MIR 3 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 294_372 | 1937 | 2702.0 | Domain | MIR 4 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 378_434 | 1937 | 2702.0 | Domain | MIR 5 | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 265_269 | 1937 | 2702.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 507_510 | 1937 | 2702.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 567_569 | 1937 | 2702.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chr8:71550783 | chr12:26636831 | ENST00000381340 | 40 | 57 | 1_2227 | 1937 | 2702.0 | Topological domain | Cytoplasmic |
Top |
Fusion Gene Sequence for LACTB2-ITPR2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>43825_43825_1_LACTB2-ITPR2_LACTB2_chr8_71550783_ENST00000522447_ITPR2_chr12_26636831_ENST00000381340_length(transcript)=5160nt_BP=877nt TTCCGCGCTGGAGTATCCAGATAGGCGACACGCCGGCGGGCGGCTGAGGCGGGAATGGCTGCTGTACTGCAGCGCGTCGAGCGGCTGTCC AATCGAGTCGTGCGTGTGTTGGGCTGTAACCCGGGTCCCATGACCCTCCAAGGCACCAACACCTACCTAGTGGGGACCGGCCCCAGGAGA ATCCTCATTGACACTGGAGAACCAGCAATTCCAGAATACATCAGCTGTTTAAAGCAGGCTCTAACTGAATTTAACACAGCAATCCAGGAA ATTGTAGTGACTCACTGGCACCGAGATCATTCTGGAGGCATAGGAGATATTTGTAAAAGCATCAATAATGACACTACCTATTGCATTAAA AAACTCCCACGGAATCCTCAGAGAGAAGAAATTATAGGAAATGGAGAGCAACAATATGTTTATCTGAAAGATGGAGATGTGATTAAGACT GAGGGAGCCACTCTAAGAGTTCTATATACCCCTGGCCACACTGATGATCACATGGCTCTACTCTTAGAAGAGGAAAATGCTATCTTTTCT GGAGATTGCATCCTAGGGGAAGGAACAACGGTATTTGAAGACCTCTATGATTATATGAACTCTTTAAAAGAGTTATTGAAAATCAAAGCT GATATTATATATCCAGGACATGGCCCAGTAATTCATAATGCTGAAGCTAAAATTCAACAATACATTTCTCACAGAAATATTCGAGAGCAG CAAATTCTTACATTATTTCGTGAGAACTTTGAGAAATCATTTACAGTAATGGAGCTTGTAAAAATTATTTACAAGAATACTCCTGAGAAT TTACATGAAATGGCTAAACATAATCTCTTACTTCATTTGAAAAAACTAGAAAAAGAAGGAAAAATATAACTTCTTGAGGAATCAAAACAA CAAAACAAATTACAACCTAGTCTGTGAGACCCTTCAGTTTCTGGACTGCATTTGTGGAAGTACAACCGGTGGCCTGGGCCTGTTGGGTCT CTACATCAATGAGAAGAATGTAGCGCTGGTCAACCAGAACCTGGAGAGCTTGACTGAGTATTGCCAGGGCCCTTGCCATGAAAATCAGAC CTGTATCGCTACACATGAGTCTAATGGGATTGATATCATCATTGCTTTGATTCTGAATGACATAAACCCTCTTGGTAAATACCGAATGGA CCTGGTGCTCCAGCTAAAGAACAATGCATCTAAACTTTTGCTGGCCATTATGGAAAGCAGACATGACAGTGAGAATGCAGAAAGAATTCT TTTTAACATGAGACCCAGAGAACTGGTGGATGTGATGAAGAATGCCTATAACCAAGGATTGGAATGTGACCATGGGGATGATGAGGGTGG AGATGATGGTGTTTCTCCAAAAGATGTTGGACACAATATCTATATTCTGGCCCATCAGTTGGCCCGCCACAATAAACTGTTGCAGCAGAT GCTCAAACCAGGATCGGATCCAGATGAAGGAGATGAAGCCTTAAAGTATTATGCCAACCACACTGCACAGATTGAGATTGTCCGGCATGA TAGGACCATGGAACAAATAGTTTTTCCTGTCCCCAATATATGTGAATACCTCACTCGAGAATCCAAGTGCCGTGTGTTCAATACAACTGA AAGGGATGAACAAGGAAGTAAAGTGAATGACTTTTTCCAGCAAACAGAAGATCTCTACAATGAAATGAAGTGGCAGAAGAAAATCAGGAA TAACCCTGCACTGTTCTGGTTCTCGAGGCACATCTCTCTCTGGGGGAGCATTTCCTTCAACCTGGCTGTGTTCATCAATTTAGCTGTTGC TCTCTTCTACCCATTTGGGGATGATGGAGATGAAGGTACACTTTCTCCATTGTTCTCGGTTCTTCTTTGGATAGCAGTTGCGATCTGCAC ATCTATGCTGTTTTTCTTCTCCAAGCCTGTGGGTATTCGGCCGTTTCTTGTATCAATAATGCTCAGATCAATATATACAATAGGTCTTGG GCCTACATTAATACTTCTTGGTGCAGCTAATCTTTGTAATAAAATTGTTTTTCTGGTGAGTTTTGTTGGAAATCGTGGCACGTTCACCCG TGGGTACCGAGCAGTCATCCTGGATATGGCCTTTCTCTATCACGTGGCGTATGTCCTGGTTTGCATGCTGGGCCTTTTTGTCCATGAATT CTTCTATAGCTTCCTGCTTTTTGATTTGGTGTACAGGGAAGAGACTTTGCTGAATGTCATAAAAAGTGTCACACGAAATGGCCGCTCTAT TATTCTAACTGCAGTCCTGGCTCTCATCCTCGTCTACCTGTTTTCCATTATTGGGTTCCTTTTTTTGAAGGATGACTTCACTATGGAAGT TGATAGGCTGAAAAACCGAACTCCTGTTACAGGCAGTCATCAAGTGCCTACTATGACTTTAACTACCATGATGGAAGCATGTGCCAAGGA GAACTGTTCACCCACAATTCCAGCTTCAAATACAGCTGATGAAGAGTATGAAGATGGAATTGAAAGGACGTGTGACACTCTCCTTATGTG CATTGTCACCGTGCTGAACCAGGGCCTCAGGAATGGCGGTGGTGTGGGGGATGTGCTAAGAAGGCCATCGAAAGATGAGCCCTTGTTTGC TGCCCGAGTGGTTTATGACCTTCTTTTTTATTTCATTGTTATCATTATTGTTCTGAACTTGATTTTTGGTGTTATCATCGATACTTTTGC TGATCTCAGAAGCGAAAAACAGAAAAAAGAAGAAATTCTAAAGACAACTTGTTTCATCTGTGGACTTGAGAGAGACAAGTTTGATAATAA AACGGTTTCATTTGAGGAGCACATTAAGTCAGAACACAATATGTGGCATTATTTGTACTTCATAGTCCTGGTGAAAGTTAAAGACCCAAC AGAATACACTGGACCTGAAAGTTATGTGGCTCAAATGATTGTGGAGAAGAATTTGGATTGGTTTCCTCGGATGCGAGCCATGTCCCTCGT TAGCAATGAAGGCGACAGTGAGCAAAATGAAATTCGGAGCCTTCAGGAGAAGTTGGAATCGACCATGAGTCTGGTCAAACAGCTGTCGGG TCAGCTGGCGGAGCTCAAGGAGCAGATGACAGAACAAAGGAAGAATAAGCAGAGACTGGGCTTCCTCGGATCAAACACACCCCATGTGAA TCATCACATGCCACCACACTGATACCATGGGGGGAAGCCGTGACTAGCCTTTCATCAGTGTCCTGCCTGATCACTGAATAAAGAACTGAG ATGGAGGGGAGTGAACAGTGCCTATTGTTGAAAAGTTAAAAACAACCAAGTGCCAAGATGTTGAGTGGGTTAGCTCCGAGAACAATTTAT AACTGTGTTTTCATGGTTGCGAAGACCTAACCTCAAATGCATCTGCTAGAAAGCGTACATCACACATTCGCAATGCATCAGGAAGAAAAG GCTTGCCCAAAAGGCTGGAGAGGGCAGGGAGCGGCAGGATGGAAGGAGACACGGGGCAGGGAGAACTCTCTTCTGCTAAATCGATAGGAG TCAGTTTTGTCTTAAATGCTGACTACAGCCACTGACATGGTTGGCTGGAATTTCTTTCTTTTAATTGTGGCATATAGGTTTGTGACACAA GAAGTCATACTTTGGTGGCTAAGTTTTACTAAGGAAAATAACTGAAAAGATTAAAAGTGAGAGCTGAAAAGAGAAATGATAATGCTTCCA AACTGTAGCTGTCACAGGGCAATTTCTTTATTTATAACATGAAGCACAATGGATTTACAGCTCTAGGAACTTAGTACTTTGGAGCTTTTG CCTCTCACACTGACAACATAACAGGATGTGATTGCCTTCTCTGGGATTCAGACAGGCTCTGTCAATGTGGAGCACAAAAGGAGATTTTCA TATAACTTGTTAAAAACATGTTCTAAGTCATGTATAGGCTAAGATTTTAAGAAGATCTGGGGGAATAAAAAGCCAACAGTAAGCCCCAGG AAAGGGTTTTTTGAGACCATATGTATGCTATTAAAATATATTGAGATTAATACATGAAAATGCTTAAAAGTGATAGGAATTATTGAGAAA CTTATGATGGTGGCATTGCCTTTTATAAACATGGAGTGAAAGCCATTTGACTCAACGTTTGCTGTGCTTAAAGAATTGCTTCAGGACCCG AGCGTTTTTATGTATGCTGTTCCTGCAGTTAGGAAAAAAAAATCCAAGAAATGTATTGAATACTCAAGAAAATGCCACATTTCAATTACA TATTTAAAACTGTATCTGTAAGGGCTTTTCAAAATGTAGCAAGATAAAAATCTCTTATTCAAATTGTTTTTGTATTAAATCATGCACTCA GAATTTGTCGAGGGAGAGAATAACCTGGTGTGTTCAGGTTATTCTTAGAGACTACACATTTGGAATAGCAGAGCAAAATATGGATAATGA AAGTGTTGGGAAAAAAGTGATGTGACAGGGAGTGAAGACACTTGATACCAGACTCTGGGAGATACTCTGCAAGTTGACCTGGCCTCTCCC CCACAGGAACAAAACACTGCCTCCAGAGTCTTTAAATTCTCAGTTATCAACGCCAAGGTTTAAGGTCTAGATAGGGTTTGCTATAGGGTT TGCTCTGACAATTTTTAAAGCTTTTGGATTGTTCTAACATAGCTTAAGCTATTGGTTCCTAAAAATCCCAAATCAAGATCTATGTAGAAT ATAAAGGAAGCCTGAACCAATCCTTCCACATACTGTTAAGATGTAGACTTGGAACAAAGCTGTTGGGACCCAGAGCAATGAATTTTTGAA CTGAAGCTACTGGTACTCCCCAGCACCACCTCATACTAAGAATTCCTCACTCTGACATGACAGTATTTTTTCTGACCAGGAGCTGAAAGA CCCTGACATTCATGATCCAAAGATATAAGAAATTTTGATATGTCTGCATGCAGCACAGAACTTTGAACCTAGGAGGCAGTCAATAAATAC ATGAGAAATTCAGCTGTCATTCAGTTACTCTTAATTCTTTATAAAACTTTAAATGATACCACATATTTGTTTGTTTAAAATGGCTTTCCC AAAATCAAAGTAGACTAAAGCAGCCATCTTTAAAATCCAGGATCATCAATGCTATTAACAGTATCAGGTAAAAAGTACACTTTAAAATAT >43825_43825_1_LACTB2-ITPR2_LACTB2_chr8_71550783_ENST00000522447_ITPR2_chr12_26636831_ENST00000381340_length(amino acids)=762AA_BP= MRNQNNKTNYNLVCETLQFLDCICGSTTGGLGLLGLYINEKNVALVNQNLESLTEYCQGPCHENQTCIATHESNGIDIIIALILNDINPL GKYRMDLVLQLKNNASKLLLAIMESRHDSENAERILFNMRPRELVDVMKNAYNQGLECDHGDDEGGDDGVSPKDVGHNIYILAHQLARHN KLLQQMLKPGSDPDEGDEALKYYANHTAQIEIVRHDRTMEQIVFPVPNICEYLTRESKCRVFNTTERDEQGSKVNDFFQQTEDLYNEMKW QKKIRNNPALFWFSRHISLWGSISFNLAVFINLAVALFYPFGDDGDEGTLSPLFSVLLWIAVAICTSMLFFFSKPVGIRPFLVSIMLRSI YTIGLGPTLILLGAANLCNKIVFLVSFVGNRGTFTRGYRAVILDMAFLYHVAYVLVCMLGLFVHEFFYSFLLFDLVYREETLLNVIKSVT RNGRSIILTAVLALILVYLFSIIGFLFLKDDFTMEVDRLKNRTPVTGSHQVPTMTLTTMMEACAKENCSPTIPASNTADEEYEDGIERTC DTLLMCIVTVLNQGLRNGGGVGDVLRRPSKDEPLFAARVVYDLLFYFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLER DKFDNKTVSFEEHIKSEHNMWHYLYFIVLVKVKDPTEYTGPESYVAQMIVEKNLDWFPRMRAMSLVSNEGDSEQNEIRSLQEKLESTMSL -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for LACTB2-ITPR2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for LACTB2-ITPR2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for LACTB2-ITPR2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |